Penile disorder
MONDO:0002036A non-neoplastic or neoplastic disorder that affects the penis. Representative examples of non-neoplastic disorders include phimosis, balanitis, and hypospadias. Representative examples of neoplastic disorders include hemangioma, penile intraepithelial neoplasia, and penile carcinoma.
Also known as: disease of penis, disease or disorder of penis, disorder of penis, penile disease, penile disorder, penis disease, penis disease or disorder
154 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Immunotherapy duo takes on rare tumors
Disease control OngoingThis phase 2 trial is testing a combination of two immunotherapy drugs, nivolumab and ipilimumab, in 798 people with over 50 types of rare cancers. The goal is to see if these drugs can shrink tumors by helping the immune system attack cancer cells. Participants receive the drugs…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New registry to monitor penile implant success in 450 men
Disease control ENROLLING_BY_INVITATIONThis study is a registry that collects real-world information on the safety and effectiveness of Boston Scientific penile implants for erectile dysfunction. It will enroll 450 men who are already scheduled to receive the implant. Researchers will track changes in erectile functio…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New triple therapy targets Hard-to-Treat cancers
Disease control OngoingThis study tests a combination of three drugs—bintrafusp alfa, PDS01ADC, and entinostat—in adults with advanced HPV-related cancers (like cervical, anal, or throat cancer) or certain colon cancers that haven't responded to standard treatment. The goal is to find a safe dose and s…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Experimental drug combo targets Hard-to-Treat cancers
Disease control OngoingThis early-phase trial tests an experimental drug called BAY 1895344 combined with standard chemotherapy (cisplatin, with or without gemcitabine) in people with advanced solid tumors, especially urothelial cancer. The goal is to find the best dose and see how safe the combination…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Can a second injection fix penile curvature?
Disease control OngoingThis study tests whether a drug called Xiaflex (collagenase clostridium histolyticum) is safe and effective for men with Peyronie's disease who have already tried platelet-rich plasma (PRP) injections. Twelve men with stable penile curvature between 30 and 90 degrees will receive…
Phase: PHASE4 • Sponsor: University of Miami • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New HPV vaccine combo aims to fight Hard-to-Treat cancers
Disease control OngoingThis study tests an HPV vaccine (PRGN-2009) alone or with a drug called M7824 in people with HPV-positive cancers like cervical, anal, and throat cancers. The goal is to find a safe dose and see if the combination boosts the immune system's attack on tumors. The trial includes 39…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug cocktail shows promise for Hard-to-Treat urinary cancers
Disease control OngoingThis early-phase study tests a combination of two or three drugs (cabozantinib, nivolumab, and sometimes ipilimumab) in people with advanced genitourinary cancers that have spread. The main goals are to find the safest doses and understand side effects. About 152 adults with vari…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could stem cells restore erectile function? new trial tests the idea
Disease control OngoingThis study tests whether stem cells from a patient's own bone marrow or fat can improve erectile dysfunction better than platelet-rich plasma or standard treatments. One hundred men with organic ED who did not respond to pills will receive one of these therapies. The goal is to s…
Phase: PHASE2 • Sponsor: National Scientific Medical Center, Kazakhstan • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for rare cancers: drug duo shows promise
Disease control OngoingThis phase II trial tests whether combining two drugs, atezolizumab and bevacizumab, can shrink rare solid tumors like appendix cancer, anal cancer, and mesothelioma. About 133 participants with various rare cancers will receive the drugs intravenously. The goal is to see if the …
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Experimental combo targets Hard-to-Treat HPV cancers
Disease control OngoingThis study tests a combination of two drugs—TG4001 (a biologic that targets HPV) and avelumab (an immunotherapy)—in people with advanced HPV-16 cancers that cannot be removed by surgery or cured by radiation. The trial has two phases: first, to find a safe dose, and second, to se…
Phase: PHASE1, PHASE2 • Sponsor: Transgene • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Can a few extra pills prevent implant infections?
Disease control OngoingThis study looks at whether taking oral antibiotics for 6 extra days after getting a penile implant can lower the chance of infection. Researchers are following 800 men for one year after surgery. The goal is to see if this simple step reduces the need for another surgery to remo…
Phase: EARLY_PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Rare cancer hope: immune drug shows promise in phase 2 trial
Disease control OngoingThis study tested a drug called pembrolizumab in 157 people with rare cancers that had spread or couldn't be removed. The drug works by helping the body's immune system attack the cancer. The main goal was to see how many patients were alive and their cancer hadn't grown after 27…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Immunotherapy duo takes on rare cancers
Disease control OngoingThis study tests whether combining two immunotherapy drugs, nivolumab and ipilimumab, can shrink tumors in people with rare cancers of the urinary or reproductive systems. About 100 adults with advanced disease that cannot be removed by surgery are taking part. The main goal is t…
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New injection shows promise for straightening penile curvature
Disease control OngoingThis study tested whether adding Fibrorestil® injections to standard care (traction therapy and pills) can better reduce penile curvature in men with Peyronie's disease. 38 men with stable curvature between 30 and 90 degrees participated. The main goal was to measure curvature ch…
Phase: NA • Sponsor: Lyx Institute • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Could a single rinse replace antibiotic cocktails in penile implant surgery?
Disease control OngoingThis study compares two methods to prevent infections during first-time penile implant surgery for erectile dysfunction. One group receives the standard antibiotic rinse, the other uses Irrisept, a simpler cleaning solution. Researchers will follow 200 men for one year after surg…
Phase: PHASE3 • Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Immunotherapy drug avelumab takes on rare penile cancer
Disease control OngoingThis phase 2 trial tests whether avelumab, an immunotherapy drug, can shrink tumors in 25 people with advanced penile cancer who cannot take platinum chemotherapy or whose cancer worsened after it. Avelumab works by blocking a protein that helps tumors hide from the immune system…
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Custom immune cells take on multiple cancers in early trial
Disease control OngoingThis early-stage study tests a new treatment called T-Plex for people with advanced solid tumors (like head and neck, cervical, or melanoma) that haven't responded to standard therapies. The treatment uses a patient's own immune cells, which are modified in a lab to recognize and…
Phase: PHASE1 • Sponsor: TScan Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could a blood injection treat erectile dysfunction? new trial investigates
Disease control ENROLLING_BY_INVITATIONThis study compares platelet-rich plasma (PRP) injections to the standard drug alprostadil (Caverject) for treating moderate to severe erectile dysfunction. Sixty men will receive both treatments in a crossover design, with each treatment given as six weekly injections. The main …
Phase: NA • Sponsor: Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New PET tracer could spot cancers that standard scans overlook
Diagnosis OngoingThis phase 1 trial is testing a new imaging tracer called 68Ga-FAPI-46 to see where it collects in normal and cancerous tissues. About 30 people with various solid tumors or blood cancers will receive the tracer and then undergo a PET/CT scan. The goal is to understand how the tr…
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
Blood test may catch pelvic cancer relapse sooner
Diagnosis OngoingThis study looks at whether a blood test that detects tumor DNA can find early signs of cancer returning in people treated for HPV-positive pelvic cancers (like cervical or anal cancer). Researchers will take blood samples from 172 patients during regular follow-up visits. The go…
Phase: NA • Sponsor: Institut Curie • Aim: Diagnosis
Last updated Jun 26, 2026 16:58 UTC
-
Liquid vs tablet: which sildenafil form do men prefer?
Symptom relief OngoingThis study looks at whether men with mild-to-moderate erectile dysfunction are more satisfied with sildenafil in a liquid suspension form compared to tablets that dissolve in the mouth. Researchers will review records of men who took each form for three months. The goal is to see…
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Nerve-Sparing radiation may help men keep sexual function after prostate cancer treatment
Symptom relief OngoingThis phase 2 trial is testing whether a special type of radiation therapy (SAbR) that avoids the nerves involved in erections can help preserve sexual function in men with localized prostate cancer. About 124 men will be randomly assigned to receive standard SAbR or a version tha…
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
New combo therapy aims to boost erections without drugs
Symptom relief OngoingThis study tests whether combining platelet-rich plasma (PRP) injections with shock wave therapy can improve erections in men with moderate erectile dysfunction. 116 men will receive either the real treatment or a placebo over 9 weeks, then be followed for 6 months. The goal is t…
Phase: NA • Sponsor: Elexial Research Limited • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Could a tiny nerve zap restore erectile function?
Symptom relief OngoingThis study tests whether low-dose electrical stimulation of the pudendal nerve can improve erectile function in men with mild to moderate erectile dysfunction. Twenty-four men will receive a 20-minute stimulation session, and researchers will measure changes in erection hardness,…
Phase: NA • Sponsor: Camilo Jose Cela University • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Could a simple nerve zap treat erectile dysfunction?
Symptom relief OngoingThis study tests whether stimulating the pudendal nerve with a small electrical current can improve erections in men with erectile dysfunction. 72 men aged 18-60 will receive either real stimulation or a sham procedure. Researchers will measure changes in erectile function, hardn…
Phase: NA • Sponsor: Camilo Jose Cela University • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Large registry launched to measure penile implant success
Knowledge-focused OngoingThis study is a registry that collects information from over 1000 men who have surgery to get a penile implant for erectile dysfunction. The main goal is to measure how satisfied patients and their partners are after the procedure. The study does not test a new treatment, but rat…
Sponsor: European Association of Urology Research Foundation • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Blood marker may reveal who benefits from ED drug
Knowledge-focused OngoingThis study looks at whether a blood test measuring the 'atherogenic index' can predict how well the drug tadalafil works for men with erectile dysfunction caused by blood vessel problems. Researchers will give 132 men tadalafil daily for one month and compare their symptom scores…
Sponsor: Taksim Egitim ve Arastirma Hastanesi • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Depression's hidden toll on male sexual function revealed
Knowledge-focused OngoingThis study looks at how the severity of depression relates to erectile dysfunction and premature ejaculation in 100 married men aged 25–60 in the Sohag region of Egypt. Participants are clinically diagnosed with depression and sexually active. Researchers will use standard questi…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Can a Men's cancer support program fit into routine care?
Knowledge-focused OngoingThis study looks at whether a 12-week survivorship program for men with advanced prostate, kidney, bladder, testicular, or penile cancer can be successfully added to their regular follow-up care. Researchers will measure how feasible and acceptable the program is using questionna…
Phase: NA • Sponsor: University College Cork • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Penile cancer patients share surgery experiences to improve future care
Knowledge-focused TerminatedThis study surveys 20 penile cancer patients who have had groin lymph node surgery at least 6 months ago. Researchers use questionnaires to learn about patients' experiences, needs, and symptoms. The goal is to find ways to improve care and education for future patients.
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Holistic education study for stress withdrawn before starting
Knowledge-focused TerminatedThis study was designed to test a holistic education program for stress management in people from colonized English-speaking countries. It aimed to help with conditions like stress, PTSD, anxiety, and fatigue using pastoral counseling and self-care activities. However, the study …
Phase: NA • Sponsor: Goddess Zena I. Jones • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Scientists investigate link between blood fats and sickle cell crises
Knowledge-focused OngoingThis study looks at how different types of fats in the blood (like cholesterol) are linked to complications in adults with sickle cell disease. Researchers will follow 116 participants from the French Caribbean islands to track their fat levels over time and during acute events l…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de la Guadeloupe • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC